CCS1.1 - NECROTIZING FACIAL MPOX INFECTION COMPLICATED BY PARADOXICAL IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME AND CONCOMITANT CUTANEOUS CMV INFECTION IN A PERSON WITH HIV
S2.3 - Reaching Patients Who Aren’t Patients: Non-traditional Settings and STI Prevention/Sexual Health – Experiences Navigating a Low Barrier Clinic at a Syringe Services Program in Miami, Florida
O2.3 - SYPHILIS TREATMENT AND CONGENITAL SYPHILIS PREVENTION EFFORTS AMONG HIGH-RISK SYPHILIS CASES REFERRED TO A SPECIALIZED INVESTIGATION TEAM IN LOS ANGELES COUNTY, OCTOBER 2022-JANUARY 2024
O2.5 - CAN SENDING BICILLIN DIRECTLY TO PROVIDERS FACILITATE SYPHILIS TREATMENT FOR PRIORITY POPULATIONS? FINDINGS FROM THE BICILLIN DELIVERY PROGRAM (SHHPDIRECTRX) IN LOUISIANA
*limited lunches available for session attendees* Lunch Symposium co-hosted by ASHA and ASTDA. The Violet Project: Creating a sexual and reproductive health innovation to reach vulnerable youth in Maryland.
12:00 PM – 1:30 PM EST
*limited lunches available for session attendees - no pre-registration* Lunch Symposium co-hosted by ASHA and ASTDA. The Violet Project: Creating a sexual and reproductive health innovation to reach vulnerable youth in Maryland.
Presenter: Saumya Sao, BA – Stanford University School of Medicine
Special Event
12:00 PM – 1:30 PM EST
Lunch Break - Lunch not provided
12:00 PM – 1:30 PM EST
Lunch Break - Lunch not provided
12:00 PM – 1:30 PM EST
STD Editorial Board Meeting (By invitation only)
12:00 PM – 1:30 PM EST
STD Editorial Board Meeting (By invitation only)
Location: 203
1:30 PM – 2:30 PM EST
Debates 1 & 2 - Debate 1: Antimicrobial Resistance Issues Should Prevent Use of Doxy PEP; Debate 2: Direct-to-Consumer STI Testing Will Increase Sexual Health Equity
O5.5 - RAPID DOXYCYCLINE POST-EXPOSURE PROPHYLAXIS (DOXYPEP) UPTAKE AND SUBSEQUENT BACTERIAL SEXUALLY TRANSMITTED INFECTIONS (BSTI) IN A BOSTON COMMUNITY HEALTH CENTER (BCHC)
O6.4 - YOUR CHOICE: 24/7 ACCESS SEXUAL, REPRODUCTIVE, AND DRUG USER HEALTH SUPPLIES VIA HARM REDUCTION VENDING MACHINES IN RHODE ISLAND – A TWO-YEAR PILOT PROJECT
O8.5 - EXAMINING CULTURE RECOVERY OF NEISSERIA GONORRHOEAE BY ANATOMIC SITE IN THE STRENGTHENING THE US RESPONSE TO RESISTANT GONORRHEA PROJECT, 2018-2022
O9.5 - ACCEPTANCE OF AND EXPERIENCES WITH DELIVERY OF EXPEDITED PARTNER THERAPY FOR STIS AMONG ADOLESCENT GIRLS AND YOUNG WOMEN USING ORAL PREP IN JOHANNESBURG, SOUTH AFRICA
O9.6 - A SIMPLE-X QUESTION: SHOULD NEONATAL HERPES SIMPLEX VIRUS INFECTION BE NATIONALLY NOTIFIABLE?
Location: 210-211
Presenter and Primary Author: Daniel L. Brook, PhD – Centers for Disease Control and Prevention
12:00 PM – 1:30 PM EST
ASTDA Awards Luncheon
12:00 PM – 1:30 PM EST
ASTDA Awards Luncheon
Location: Salon West
Special Event
12:00 PM – 1:30 PM EST
Lunch break - lunch not provided
12:00 PM – 1:30 PM EST
Lunch break - lunch not provided
1:30 PM – 2:30 PM EST
Debates 3 & 4 - Debate 3: Heterosexual Men Should Be a Higher Priority in STI Control Activities; Debate 4: All STI Prevention Resources Should Be Focused on High Priority Populations
Moderator: Susan Tuddenham, MD, MPH – Johns Hopkins University School of Medicine - Division of Infectious DIseases
CE Available: CE Code G
1:30 PM – 2:30 PM EST
Debate 3: Heterosexual Men Should Be a Higher Priority in STI Control Activities; Debate 4: All STI Prevention Resources Should be Focused on High Priority Populations
O10.2 - FREQUENCY OF 4-FOLD NON-TREPONEMAL TITER DIFFERENTIALS BETWEEN INFANTS AND BIRTH PARENTS AMONG INFANTS EXPOSED TO SYPHILIS IN UTERO AND IMPLICATIONS ON CONGENITAL SYPHILIS CASE CLASSIFICATION
Location: Salon West
Presenter and Co-author: Mundayi V. Nlandu, MPH – Oak Ridge Institute for Science and Education
3:00 PM – 4:15 PM EST
O10.3 - ASSESSMENT OF NEONATAL JAUNDICE AND ELEVATED CEREBROSPINAL FLUID WHITE BLOOD CELL COUNT OR PROTEIN AS EVIDENCE OF CONGENITAL SYPHILIS, SET-NET, 2018-2021
O10.5 - CHARACTERISTICS OF PEOPLE DELIVERING A BABY WITH CONGENITAL SYPHILIS AND MISSED OPPORTUNITIES TO PREVENT CONGENITAL SYPHILIS, NYC, 2018-2022
Location: Salon West
Presenter and Primary Author: Robin R. Hennessy, MPH (she/her/hers) – Centers for Disease Control and Prevention/New York City Department of Health and Mental Hygiene
3:00 PM – 4:15 PM EST
O10.6 - (WITHDRAWN) MISSED PREVENTION OPPORTUNITIES IN CONGENITAL SYPHILIS CASES IN A SANCTUARY CITY
Location: Salon West
3:00 PM – 4:15 PM EST
Oral Session (O11) - Syphilis Knows No Bounds: Understanding the Effects of Syphilis Among All Genders and Sexualities
O11.2 - SEX OF PARTNERS REPORTED BY WOMEN DIAGNOSED WITH PRIMARY AND SECONDARY SYPHILIS IN NEW YORK CITY, 2013 TO 2022
Location: 210-211
Presenter and Primary Author: Zachary Heth, MPH – New York City Department of Health and Mental Hygiene
3:00 PM – 4:15 PM EST
O11.3 - PRELIMINARY RESULTS FROM A CLINICAL TRIAL COMPARING THE EFFICACY OF CEFIXIME VERSUS PENICILLIN G FOR THE TREATMENT OF EARLY SYPHILIS
Location: 210-211
Presenter and Primary Author: Kori Keith, MPH, BA (she/her/hers) – Department of Population and Public Health Sciences, University of Southern California
3:00 PM – 4:15 PM EST
O11.4 - ASSESSMENT OF CHANGING SYPHILIS DYNAMICS IN MEN AND WOMEN, NORTH CAROLINA, 2023
Location: 210-211
Presenter and Primary Author: Erika Samoff, MPH, PhD – North Carolina Department of Health and Human Services
3:00 PM – 4:15 PM EST
O11.5 - SYPHILIS AMONG TRANSGENDER WOMEN — UNITED STATES, 2022
O13.1 - ORAL ZOLIFLODACIN FOR TREATMENT OF UNCOMPLICATED GONORRHEA: SUBGROUP ANALYSES BY RACE AND REGION OF A GLOBAL PHASE 3 RANDOMIZED CONTROLLED CLINICAL TRIAL
O13.3 - GEPOTIDACIN AND CEFTRIAXONE/AZITHROMYCIN EFFICACY BY BASELINE PHENOTYPES AND GENOTYPES OF NEISSERIA GONORRHOEAE RECOVERED FROM A CLINICAL TRIAL FOR UNCOMPLICATED UROGENITAL GONORRHEA (EAGLE-1)
O14.4 - EVALUATING THE PERFORMANCE OF THE SYPHILIS HEALTH CHECK RAPID TEST AS A SCREENING TOOL FOR PEOPLE WHO INJECT DRUGS (PWID), ENCOUNTERED IN NON-CLINICAL SETTINGS IN LOS ANGELES COUNTY (LAC), 2022
O15.4 - INCREASING PREVALENCE OF TETRACYCLINE RESISTANT GONORRHEA AMONG SEXUALLY TRANSMITTED INFECTION (STI) CLINIC PATIENTS IS CORRELATED WITH INCREASING USE OF DOXYCYCLINE FOR TREATMENT AND POST-EXPOSURE PROPHYLAXIS (DOXY-PEP), SAN FRANCISCO, 2002-2023
Location: Salon West
Presenter and Primary Author: Robert P. Kohn, MPH – San Francisco Department of Public Health
8:00 AM – 9:15 AM EST
O15.5 - IMPACT OF PREGNANCY ON THE ASSOCIATION BETWEEN METHAMPHETAMINE USE AND SYPHILIS TREATMENT IN LOS ANGELES COUNTY
S12.6 - THE REVERSE SEQUENCE ALGORITHM IS LESS COST-EFFECTIVE THAN THE TRADITIONAL ALGORITHM AT SCREENING FOR SYPHILIS AMONG GAY, BISEXUAL, AND OTHER MEN WHO HAVE SEX WITH MEN AND PREVENTING CONGENITAL SYPHILIS AMONG PREGNANT PEOPLE
O16.4 - IN VITRO ACTIVITY OF GEPOTIDACIN AGAINST BASELINE NEISSERIA GONORRHOEAE PHENOTYPES AND GENOTYPES RECOVERED FROM A CLINICAL TRIAL FOR UNCOMPLICATED UROGENITAL GONORRHEA (EAGLE-1)
O16.5 - EXPANDED SURRG CASE INVESTIGATION OUTCOMES AMONG PATIENTS DIAGNOSED WITH GONORRHEA WITH REDUCED ANTIMICROBIAL SUSCEPTIBILITY IN NEW YORK CITY, 2017-2021
Moderator: John R. Papp, PhD – Centers for Disease Control and Prevention
9:30 AM – 10:45 AM EST
O17.1 - RECENT DOXY-PEP USE, TETRACYCLINE-RESISTANT STAPHYLOCOCCUS AUREUS, AND GROUP A STREPTOCOCCUS CARRIAGE AMONG SEXUAL HEALTH CLINIC PATIENTS IN SEATTLE, WASHINGTON
O17.5 - DOXYCYCLINE POST-EXPOSURE PROPHYLAXIS (DOXY-PEP) IS ASSOCIATED WITH DECLINES IN CITYWIDE CHLAMYDIA IN MSM AND TRANSGENDER WOMEN IN SAN FRANCISCO, AND DECLINES WERE SIMILAR FOR WHITE AND LATINX POPULATIONS
O18.1 - RACISM AND DISCRIMINATION IMPACTS SEXUAL HEALTH OF BLACK ADOLESCENT
Location: 212-213-214
Presenter and Primary Author: Ashley V. Hill, DrPH, MPH (she/her/hers) – University of Illinois Chicago School of Public Health/ Center of Excellence in Maternal and Child Health
9:30 AM – 10:45 AM EST
O18.2 - RAPID ETHNOGRAPHIC ASSESSMENT OF GENERAL AND SEXUAL HEALTH-SEEKING BEHAVIORS AMONG YOUNG BLACK WOMEN IN DETROIT
Location: 212-213-214
Presenter and Co-Author: Jill C. Diesel, PhD, MPH (she/her/hers) – Centers for Disease Control and Prevention / Michigan Department of Health and Human Services
9:30 AM – 10:45 AM EST
O18.3 - CHLAMYDIA PRESCRIBING PRACTICES AFTER CHANGES TO NATIONAL TREATMENT GUIDELINES, UNITED STATES (US) 2016 – 2022
O18.4 - (WITHDRAWN) ASIAN AMERICAN YOUNG ADULT WOMEN'S EXPERIENCE TALKING WITH MOTHERS ABOUT SEXUAL HEALTH IN THE UNITED STATES
Location: 212-213-214
9:30 AM – 10:45 AM EST
O18.5 - BIOLOGIC FALSE POSITIVE SYPHILIS RESULTS AMONG UNACCOMPANIED CHILDREN IN THE CARE OF THE U.S. OFFICE OF REFUGEE RESETTLEMENT — UNITED STATES, 2023
Location: 212-213-214
Presenter and Primary Author: Kelly Garcia-Eberhardt, MPH (she/her/hers) – Office of Refugee Resettlement, Administration for Children & Families, U.S. Health and Human Services
9:30 AM – 10:45 AM EST
O18.6 - (WITHDRAWN) ACCESS TO GENDER-AFFIRMING HORMONE THERAPY FACILITATES UPTAKE IN STI PREVENTION: AN EXPLORATORY STUDY
.png)